Year: 2014
Type: review
Source: The Lancet Oncology
Authors: Jack Cuzick, Mangesh A Thorat, Gerald Andriole, Otis W Brawley, Powel H Brown, Zoran Culig, Rosalind A Eeles, Leslie G Ford, Freddie C Hamdy, Lars Holmberg, Dragan Ilic, Timothy J Key, Carlo La Vecchia, Hans Lilja, Michael Marberger, Frank L Meyskens, Lori M Minasian, Chris Parker, Howard L Parnes, Sven Perner, Harry Rittenhouse, Jack Schalken, Hans-Peter Schmid, Bernd J Schmitz-Dräger, Fritz H Schröder, Arnulf Stenzl, Bertrand Tombal, Timothy J Wilt, Alicja Wolk
Institutions: Queen Mary University of London, Barnes-Jewish Hospital, Washington University in St. Louis, American Cancer Society, Emory University, The University of Texas MD Anderson Cancer Center, Innsbruck Medical University, Universität Innsbruck, Royal Marsden NHS Foundation Trust, Institute of Cancer Research, National Cancer Institute, University of Oxford, Uppsala University, King's College London, Monash University, University of Milan, Memorial Sloan Kettering Cancer Center, Lund University, University of Vienna, Medical University of Vienna, University of California, Irvine, National Institutes of Health, University Hospital Bonn, Radboud University Medical Center, Kantonsspital St. Gallen, Schön Klinik Nürnberg Fürth, Erasmus MC, Universitätsklinikum Tübingen, UCLouvain, University of Minnesota, Minneapolis VA Health Care System, Minneapolis VA Medical Center, Karolinska Institutet
Language: English
Subfield: Urology
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
Awards: 7th International Conference on Clinical Cancer Prevention 2012 with Consensus Co, NIHR Senior Investigator Award, G4192692896, Prospective validation of a multi-marker prostate cancer prediction model, G6544375666, G6723261869, G697149933, G8712112369, Cancer Center Support Grant, Cancer Center Support Grant, SPORE in Prostate Cancer
OpenAlex ID: W2149323915